<DOC>
	<DOC>NCT00760578</DOC>
	<brief_summary>The purpose of this study is to determine if MSDC-0160 is effective in the treatment of Type 2 diabetes.</brief_summary>
	<brief_title>A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Diagnosis of Type 2 Diabetes naive or on metformin Male and female (postmenopausal or surgically sterilized), 18 to 70 years of age. Use of diabetes medications other than metformin. History of heart failure or previous myocardial infarction. Blood pressure great than 160/100 mmHg.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>